Drugs against newly identified targets might be developed with potentially fewer side effectsAlmost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis. After publishing this discovery in Nature, the researchers decided to use this mouse model to study the underlying molecular pathways involved in disease development, and to look for innovative and efficient therapies.
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment